MRPL12 K163 acetylation inhibits ccRCC via driving mitochondrial metabolic reprogramming

重编程 乙酰化 细胞生物学 线粒体 化学 生物 生物化学 细胞 基因
作者
Xingzhao Ji,Fuyuan Xue,Ying Wang,Dexuan Gao,Jian Sun,Tianyi Dong,Qian Mu,Quanlin Xu,Shengnan Sun,Yi Liu,Qiang Wan
出处
期刊:Cell Death and Disease [Springer Nature]
卷期号:16 (1): 646-646
标识
DOI:10.1038/s41419-025-07896-3
摘要

Renal cell carcinoma (RCC) is a common urological tumor, with clear cell renal cell carcinoma (ccRCC) being the most prevalent subtype. Metabolic reprogramming plays a critical role in ccRCC progression, making it a promising target for therapeutic intervention, though effective treatments remain unavailable. Our previous studies have shown that mitochondrial ribosomal protein L12 (MRPL12) contributes to various metabolic diseases, including diabetic kidney disease and HCC, by regulating mitochondrial biosynthesis. In this study, we demonstrated that MRPL12 is acetylated at lysine 163 (K163) in ccRCC cells, a key modification that influences its regulatory effect on mitochondrial metabolism. Mechanistically, we clarified that acetylation at the K163 site enhances mitochondrial biosynthesis by promoting MRPL12's binding to POLRMT, which subsequently increases mitochondrial metabolism and suppresses cellular glycolysis. Additionally, we found that MRPL12 K163 acetylation levels were significantly downregulated in ccRCC and that restoring this acetylation inhibited ccRCC progression in both in vitro and in vivo models. Furthermore, we demonstrated that the acetyltransferase TIP60 and the deacetylase SIRT5 bind to MRPL12 and regulate its acetylation. These findings highlight K163 acetylation as a critical site for MRPL12-mediated regulation of mitochondrial metabolism and reveal that this modification inhibits renal cancer development by promoting mitochondrial biosynthesis, reducing glycolysis, and driving metabolic reprogramming. This study suggests a potential therapeutic strategy for targeting MRPL12 acetylation in ccRCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zys2001mezy完成签到,获得积分10
刚刚
无极微光的应助被赶紧毕业采纳,获得20
刚刚
刚刚
西西完成签到 ,获得积分10
刚刚
塰嗨海完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
2秒前
aajhajkahna的应助被Mickey采纳,获得10
2秒前
很执着的白萱完成签到,获得积分10
2秒前
科研通AI6.3的应助被jinge采纳,获得10
2秒前
科研通AI6.2的应助被jinge采纳,获得10
2秒前
3秒前
程朗发布了新的文献求助10
3秒前
启程牛牛完成签到,获得积分10
3秒前
DW的应助被SanXing三醒采纳,获得10
4秒前
SciGPT的应助被Ma采纳,获得10
4秒前
4秒前
5秒前
5秒前
爱撒娇的安青完成签到,获得积分10
6秒前
abandon发布了新的文献求助10
6秒前
岳鑫发布了新的文献求助10
7秒前
Czz发布了新的文献求助10
7秒前
zjy发布了新的文献求助10
7秒前
启程牛牛发布了新的文献求助10
7秒前
pinkangel发布了新的文献求助10
9秒前
cdercder的应助被Vermouth采纳,获得10
9秒前
舒适香露发布了新的文献求助10
9秒前
elo完成签到,获得积分10
9秒前
9秒前
安静的缘分完成签到,获得积分10
10秒前
科研通AI2S的应助被栗米椰采纳,获得10
10秒前
10秒前
科研通AI6.4的应助被程朗采纳,获得10
10秒前
10秒前
叫滚滚发布了新的文献求助10
10秒前
11秒前
科研通AI65的应助被全或无采纳,获得20
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183241
求助须知:如何正确求助?哪些是违规求助? 9572493
关于积分的说明 21826218
捐赠科研通 7780115
什么是DOI,文献DOI怎么找? 3433982
关于科研通互助平台的介绍 2558103
邀请新用户注册赠送积分活动 2480192